ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Umoja Biopharma raises $210m to develop cancer treatments pharmaceutical-technology
June 17, 2021Umoja Biopharma has raised $210m in a Series B funding round to progress its pipeline of in vivo engineered CAR T cell immunotherapies for the treatment of solid tumours and hematologic malignancies into the clinic.
Pharma Sources Insight January 2025
